Table of Contents Table of Contents
Previous Page  354 / 464 Next Page
Information
Show Menu
Previous Page 354 / 464 Next Page
Page Background

354

EXHIBITION

| Programme and Exhibition Guide

Is there anything that can stop

Proton Therapy from being a

future standard of care?

iba-protontherapy.com

Do not miss the IBA lunch symposium on

Saturday 6

th

of May, Room Schubert, 13:15-14:15

Should more patients be treated with Proton Therapy?

Prof. Dr. Mechthild Krause, MD

Director, Oncoray - Institute of Radiation Oncology, Helmholtz-Zentrum Dresden-Rossendorf, Germany.

Chairman

Prof. Dr. Michael Baumann, MD

Chairman and scientific director, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Proton Therapy: New treatment modality in our armamentarium

Prof. Dr. James M. Metz, MD

Chair of Radiation Oncology, University of Pennsylvania, Perelman Center for Advanced Medicine, PA, USA.